{"id":"https://openalex.org/W4386928780","doi":"https://doi.org/10.1177/17562864231195513","title":"A post hoc evaluation of the shift in spasticity category in individuals with multiple sclerosis-related spasticity treated with nabiximols","display_name":"A post hoc evaluation of the shift in spasticity category in individuals with multiple sclerosis-related spasticity treated with nabiximols","publication_year":2023,"publication_date":"2023-01-01","ids":{"openalex":"https://openalex.org/W4386928780","doi":"https://doi.org/10.1177/17562864231195513","pmid":"https://pubmed.ncbi.nlm.nih.gov/37745913","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10515604"},"language":"en","primary_location":{"id":"doi:10.1177/17562864231195513","doi":"https://doi.org/10.1177/17562864231195513","is_oa":true,"landing_page_url":"https://doi.org/10.1177/17562864231195513","pdf_url":null,"source":{"id":"https://openalex.org/S7261370","display_name":"Therapeutic Advances in Neurological Disorders","issn_l":"1756-2856","issn":["1756-2856","1756-2864"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Advances in Neurological Disorders","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1177/17562864231195513","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057108711","display_name":"Clara Grazia Chisari","orcid":"https://orcid.org/0000-0003-1607-543X","observed_orcids":["https://orcid.org/0000-0003-1607-543X"]},"institutions":[{"id":"https://openalex.org/I39063666","display_name":"University of Catania","ror":"https://ror.org/03a64bh57","country_code":"IT","type":"education","lineage":["https://openalex.org/I39063666"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Clara Grazia Chisari","raw_affiliation_strings":["Department of Medical and Surgical Sciences and Advanced Technologies \u2018GF Ingrassia\u2019, Multiple Sclerosis Center, University of Catania, Catania, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical and Surgical Sciences and Advanced Technologies \u2018GF Ingrassia\u2019, Multiple Sclerosis Center, University of Catania, Catania, Italy","institution_ids":["https://openalex.org/I39063666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115601369","display_name":"Joe Guadagno","orcid":"https://orcid.org/0000-0003-4802-0281","observed_orcids":["https://orcid.org/0000-0003-4802-0281"]},"institutions":[{"id":"https://openalex.org/I2800516725","display_name":"Royal Victoria Infirmary","ror":"https://ror.org/01p19k166","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800516725","https://openalex.org/I2801663869"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Joe Guadagno","raw_affiliation_strings":["Department of Neurology, Royal Victoria Infirmary, Newcastle upon Tyne, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Royal Victoria Infirmary, Newcastle upon Tyne, UK","institution_ids":["https://openalex.org/I2800516725"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025896953","display_name":"Peyman Adjamian","orcid":"https://orcid.org/0000-0002-3796-380X","observed_orcids":["https://orcid.org/0000-0002-3796-380X"]},"institutions":[{"id":"https://openalex.org/I4210152300","display_name":"Jazz Pharmaceuticals (Ireland)","ror":"https://ror.org/055mhsv54","country_code":"IE","type":"company","lineage":["https://openalex.org/I4210152300"]},{"id":"https://openalex.org/I85384539","display_name":"GW Pharmaceuticals (United Kingdom)","ror":"https://ror.org/01gtctx88","country_code":"GB","type":"company","lineage":["https://openalex.org/I85384539"]}],"countries":["GB","IE"],"is_corresponding":false,"raw_author_name":"Peyman Adjamian","raw_affiliation_strings":["GW Pharmaceuticals, Cambridge, UK","Jazz Pharmaceuticals, Inc., Dublin, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GW Pharmaceuticals, Cambridge, UK","institution_ids":["https://openalex.org/I85384539"]},{"raw_affiliation_string":"Jazz Pharmaceuticals, Inc., Dublin, Ireland","institution_ids":["https://openalex.org/I4210152300"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058239803","display_name":"Carlos Vila Silv\u00e1n","orcid":"https://orcid.org/0000-0001-5541-7848","observed_orcids":["https://orcid.org/0000-0001-5541-7848"]},"institutions":[{"id":"https://openalex.org/I4210122008","display_name":"Almirall (Spain)","ror":"https://ror.org/03qsven24","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210122008"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Carlos Vila Silvan","raw_affiliation_strings":["Almirall SA, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Almirall SA, Barcelona, Spain","institution_ids":["https://openalex.org/I4210122008"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Teresa Greco","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210129872","display_name":"Jazz Pharmaceuticals (Italy)","ror":"https://ror.org/039vtmd91","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210129872","https://openalex.org/I4210152300"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Teresa Greco","raw_affiliation_strings":["Jazz Pharmaceuticals \u2013 Gentium Srl, Villa Guardia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jazz Pharmaceuticals \u2013 Gentium Srl, Villa Guardia, Italy","institution_ids":["https://openalex.org/I4210129872"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112838131","display_name":"Makarand Bagul","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152300","display_name":"Jazz Pharmaceuticals (Ireland)","ror":"https://ror.org/055mhsv54","country_code":"IE","type":"company","lineage":["https://openalex.org/I4210152300"]},{"id":"https://openalex.org/I85384539","display_name":"GW Pharmaceuticals (United Kingdom)","ror":"https://ror.org/01gtctx88","country_code":"GB","type":"company","lineage":["https://openalex.org/I85384539"]}],"countries":["GB","IE"],"is_corresponding":false,"raw_author_name":"Makarand Bagul","raw_affiliation_strings":["GW Pharmaceuticals, Cambridge, UK","Jazz Pharmaceuticals, Inc., Dublin, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GW Pharmaceuticals, Cambridge, UK","institution_ids":["https://openalex.org/I85384539"]},{"raw_affiliation_string":"Jazz Pharmaceuticals, Inc., Dublin, Ireland","institution_ids":["https://openalex.org/I4210152300"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071409158","display_name":"Francesco Patti","orcid":"https://orcid.org/0000-0002-6923-0846","observed_orcids":["https://orcid.org/0000-0002-6923-0846"]},"institutions":[{"id":"https://openalex.org/I39063666","display_name":"University of Catania","ror":"https://ror.org/03a64bh57","country_code":"IT","type":"education","lineage":["https://openalex.org/I39063666"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Francesco Patti","raw_affiliation_strings":["Department of Medical and Surgical Sciences and Advanced Technologies \u2018GF Ingrassia\u2019, Multiple Sclerosis Center, University of Catania Italy"],"raw_orcid":"https://orcid.org/0000-0002-6923-0846","affiliations":[{"raw_affiliation_string":"Department of Medical and Surgical Sciences and Advanced Technologies \u2018GF Ingrassia\u2019, Multiple Sclerosis Center, University of Catania Italy","institution_ids":["https://openalex.org/I39063666"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5071409158"],"corresponding_institution_ids":["https://openalex.org/I39063666"],"apc_list":{"value":2300,"currency":"USD","value_usd":2300},"apc_paid":{"value":2300,"currency":"USD","value_usd":2300},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":null,"first_page":"17562864231195513","last_page":"17562864231195513"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11274","display_name":"Botulinum Toxin and Related Neurological Disorders","score":0.9047999978065491,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11274","display_name":"Botulinum Toxin and Related Neurological Disorders","score":0.9047999978065491,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.06689999997615814,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10414","display_name":"Cannabis and Cannabinoid Research","score":0.016599999740719795,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.8410000205039978},{"id":"https://openalex.org/keywords/spasticity","display_name":"spasticity","score":0.824999988079071},{"id":"https://openalex.org/keywords/nabiximols","display_name":"nabiximols","score":0.9959999918937683},{"id":"https://openalex.org/keywords/cannabis-based-medicines","display_name":"cannabis-based medicines","score":0.6930000185966492},{"id":"https://openalex.org/keywords/spasticity-severity","display_name":"spasticity severity","score":0.9150000214576721},{"id":"https://openalex.org/keywords/savants","display_name":"savants","score":0.890999972820282},{"id":"https://openalex.org/keywords/real-world-evidence","display_name":"real-world evidence","score":0.6359999775886536}],"concepts":[{"id":"https://openalex.org/C2779012798","wikidata":"https://www.wikidata.org/wiki/Q117060","display_name":"Spasticity","level":2,"score":0.9171125888824463},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8094438314437866},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.7557756900787354},{"id":"https://openalex.org/C99508421","wikidata":"https://www.wikidata.org/wiki/Q2678675","display_name":"Physical medicine and rehabilitation","level":1,"score":0.5653039216995239},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.5436193346977234},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.4466245770454407},{"id":"https://openalex.org/C2992886853","wikidata":"https://www.wikidata.org/wiki/Q18381816","display_name":"Post hoc","level":2,"score":0.42018646001815796},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.32562610507011414},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20295625925064087},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.17297011613845825},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.15785855054855347}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1177/17562864231195513","doi":"https://doi.org/10.1177/17562864231195513","is_oa":true,"landing_page_url":"https://doi.org/10.1177/17562864231195513","pdf_url":null,"source":{"id":"https://openalex.org/S7261370","display_name":"Therapeutic Advances in Neurological Disorders","issn_l":"1756-2856","issn":["1756-2856","1756-2864"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Advances in Neurological Disorders","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10515604","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10515604","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10515604/pdf/10.1177_17562864231195513.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ther Adv Neurol Disord","raw_type":"Text"},{"id":"pmid:37745913","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37745913","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic advances in neurological disorders","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:ac888780ed304cd2a775d85a52dfd25f","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/ac888780ed304cd2a775d85a52dfd25f","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Therapeutic Advances in Neurological Disorders, Vol 16 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1177/17562864231195513","doi":"https://doi.org/10.1177/17562864231195513","is_oa":true,"landing_page_url":"https://doi.org/10.1177/17562864231195513","pdf_url":null,"source":{"id":"https://openalex.org/S7261370","display_name":"Therapeutic Advances in Neurological Disorders","issn_l":"1756-2856","issn":["1756-2856","1756-2864"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Advances in Neurological Disorders","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320308604","display_name":"Biogen","ror":"https://ror.org/02jqkb192"},{"id":"https://openalex.org/F4320308970","display_name":"Teva Pharmaceutical Industries","ror":"https://ror.org/01wfv3m53"},{"id":"https://openalex.org/F4320312570","display_name":"Jazz Pharmaceuticals","ror":"https://ror.org/055mhsv54"},{"id":"https://openalex.org/F4320332096","display_name":"Jazz Pharmaceuticals Canada","ror":null},{"id":"https://openalex.org/F4320333587","display_name":"Sanofi Genzyme","ror":null}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4386928780.pdf","grobid_xml":"https://content.openalex.org/works/W4386928780.grobid-xml"},"referenced_works_count":18,"referenced_works":["https://openalex.org/W1801725150","https://openalex.org/W1973987251","https://openalex.org/W1987910245","https://openalex.org/W1993448410","https://openalex.org/W1998350384","https://openalex.org/W2001312027","https://openalex.org/W2043053000","https://openalex.org/W2060715958","https://openalex.org/W2069564502","https://openalex.org/W2090651652","https://openalex.org/W2136571523","https://openalex.org/W2142081611","https://openalex.org/W2149459253","https://openalex.org/W2345773636","https://openalex.org/W2803556125","https://openalex.org/W2884177512","https://openalex.org/W2970610923","https://openalex.org/W3204491563"],"related_works":["https://openalex.org/W4280558889","https://openalex.org/W2120992604","https://openalex.org/W4389373995","https://openalex.org/W4389366094","https://openalex.org/W4367609561","https://openalex.org/W4391576137","https://openalex.org/W2075298115","https://openalex.org/W4385406505","https://openalex.org/W4389446756","https://openalex.org/W4391780143"],"abstract_inverted_index":{"Background:":[0],"Over":[1],"80%":[2,163],"of":[3,19,43,120,164,179,188,199,207],"individuals":[4],"with":[5,29,46,80,122,167,192],"multiple":[6],"sclerosis":[7],"(MS)":[8],"experience":[9],"MS-associated":[10],"spasticity":[11,169,180,200],"(MSS).":[12],"In":[13,114,158],"many":[14],"European":[15],"countries,":[16],"after":[17,181],"failure":[18],"first-line":[20],"treatments,":[21],"moderate":[22,106],"or":[23,51,56,109],"severe":[24,110,123,168],"MSS":[25,124,189],"can":[26],"be":[27],"treated":[28,45,191],"nabiximols,":[30],"a":[31,126,173,176,196],"cannabis-based":[32],"add-on":[33],"treatment.":[34],"Objective:":[35],"This":[36],"post":[37],"hoc":[38],"analysis":[39],"assessed":[40,165],"the":[41,93,115,118,205,208],"shift":[42,119,174],"participants":[44,121],"nabiximols":[47,138,193],"from":[48,63],"higher":[49],"(severe":[50],"moderate)":[52],"to":[53,195,204],"lower":[54,127,177,197],"(moderate":[55],"mild/none)":[57],"spasticity.":[58],"Methods:":[59],"Previously":[60],"published":[61],"data":[62],"two":[64,116],"randomised":[65],"controlled":[66],"trials":[67],"(RCTs),":[68],"GWSP0604":[69],"(NCT00681538)":[70],"and":[71,74],"SAVANT":[72],"(EudraCT2015-004451-40),":[73],"one":[75],"large":[76],"real-world":[77],"study":[78,210],"(consistent":[79],"EU":[81],"label),":[82],"all":[83,159],"enriched":[84],"for":[85,135],"responders,":[86],"were":[87],"re-analysed.":[88],"Spasticity":[89],"severity,":[90,201],"measured":[91],"using":[92],"0\u201310":[94],"numerical":[95],"rating":[96],"scale":[97],"(spasticity":[98],"NRS),":[99],"was":[100,129],"categorised":[101],"as":[102],"none/mild":[103],"(score":[104,107,111],"<4),":[105],"\u2a7e4\u20137),":[108],"\u2a7e7).":[112],"Results:":[113],"RCTs,":[117],"into":[125,175],"category":[128,178,198],"significantly":[130],"greater":[131],"at":[132,170],"week":[133],"12":[134,182],"those":[136],"receiving":[137],"versus":[139],"placebo":[140],"[GWSP0604:":[141],"OR":[142],"(95%":[143],"CI),":[144],"4.4":[145],"(1.4,":[146],"14.2),":[147],"p":[148,155],"=":[149,156],"0.0125;":[150],"SAVANT:":[151],"5.2":[152],"(1.2,":[153],"22.3),":[154],"0.0267].":[157],"three":[160],"studies,":[161],"over":[162],"patients":[166,190],"baseline":[171],"reported":[172],"weeks.":[183],"Conclusions:":[184],"A":[185],"meaningful":[186],"proportion":[187],"shifted":[194],"typically":[202],"maintained":[203],"end":[206],"12-week":[209],"period.":[211]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-09-22T00:00:00"}